Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine
- PMID: 1929243
- PMCID: PMC284286
- DOI: 10.1128/AAC.35.6.1060
Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine
Abstract
The combined cytotoxicity of zidovudine and ganciclovir in three cell lines of human origin was examined. The data were generated by a new rapid cell proliferation assay and a more sensitive plating efficiency assay. A three-dimensional analytical approach was used to evaluate the drug-drug interactions, and the results were compared with those obtained by two conventional methods of analysis. Synergistic cytotoxicity was observed in all cell lines examined and by both assays. Moreover, this synergistic cytotoxicity was statistically significant at physiologically relevant concentrations. It is not known whether these drug-drug interactions manifest themselves in vivo as granulocytopenia or other untoward side effects. These results, however, indicate that further investigation is warranted and that the coadministration of zidovudine and ganciclovir may be contraindicated.
Similar articles
-
Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.Antimicrob Agents Chemother. 1992 May;36(5):1127-30. doi: 10.1128/AAC.36.5.1127. Antimicrob Agents Chemother. 1992. PMID: 1510405 Free PMC article.
-
Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo. Freitas, V.R., Fraser-Smith, E.B., Chiu, S., Michelson, S. and Schatzman, R.C. (1993) Antiviral Res. 21, 301-315.Antiviral Res. 1994 Aug;24(4):357-64. doi: 10.1016/0166-3542(94)90082-5. Antiviral Res. 1994. PMID: 7993079 No abstract available.
-
Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells.Cancer Commun. 1990;2(4):129-33. doi: 10.3727/095535490820874498. Cancer Commun. 1990. PMID: 2369552
-
Concomitant ganciclovir and zidovudine treatment for cytomegalovirus retinitis in patients with HIV infection: an approach to treatment.J Acquir Immune Defic Syndr (1988). 1991;4 Suppl 1:S16-21. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1848617 Review.
-
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.Drugs. 1994 Aug;48(2):199-226. doi: 10.2165/00003495-199448020-00007. Drugs. 1994. PMID: 7527325 Review.
Cited by
-
The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.Antimicrob Agents Chemother. 2016 Sep 23;60(10):6179-88. doi: 10.1128/AAC.03046-15. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27503639 Free PMC article.
-
Antiviral therapy: current concepts and practices.Clin Microbiol Rev. 1992 Apr;5(2):146-82. doi: 10.1128/CMR.5.2.146. Clin Microbiol Rev. 1992. PMID: 1576586 Free PMC article. Review.
-
Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.Antimicrob Agents Chemother. 2004 Oct;48(10):3918-27. doi: 10.1128/AAC.48.10.3918-3927.2004. Antimicrob Agents Chemother. 2004. PMID: 15388453 Free PMC article.
-
Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.Oncogene. 2020 Feb;39(9):2009-2023. doi: 10.1038/s41388-019-1122-x. Epub 2019 Nov 26. Oncogene. 2020. PMID: 31772331
-
Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells.Br J Cancer. 2012 Nov 6;107(10):1692-701. doi: 10.1038/bjc.2012.450. Epub 2012 Oct 4. Br J Cancer. 2012. PMID: 23037716 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources